Human heart-type cytoplasmic fatty acid-binding protein (H-FABP) for the diagnosis of acute myocardial infarction. Clinical evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzyme MB

Clinical Chemistry and Laboratory Medicine

Volumn 38, Issue 3, 2000, Pages 231-238

  Okamoto, Fumio ^a   Sohmiya, Koichi ^a   Ohkaru, Yasuhiko ^b   Kawamura, Keishiro ^a   Asayama, Kumiko ^b   Kimura, Hiroshi ^b   Nishimura, Shinzo ^b   Ishii, Hiroo ^b   Sunahara, Noriyuki ^b   Tanaka, Takao ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

Acute myocardial infarction; Clinical evaluation; Diagnosis; Enzyme linked immunosorbent assay; Human heart type cytoplasmic fatty acid binding protein

Indexed keywords

BIOCHEMICAL MARKER; CREATINE KINASE MB; FATTY ACID BINDING PROTEIN; MONOCLONAL ANTIBODY; MYOGLOBIN;

ACUTE HEART INFARCTION; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; RECEIVER OPERATING CHARACTERISTIC; SYMPTOM; THORAX PAIN;

EID: 0034042774     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2000.034     Document Type: Article

References (31)

1. Bernard R. Nomenclature and criteria for diagnostic of ischemic heart disease. Circulation 1979; 59:607-9.
2. Shell WE, Kjekshus JK, Sobel BE. Quantitative assessment of the extent of myocardial infarction in the conscious dog by means of analysis of serial changes in serum creatine phosphokinase activity. J Clin Invest 1971; 50:2614-25.
3. Irvin RG, Cobb FR, Rose CR. Acute myocardial infarction and MB creatine phosphokinase. Relationship between onset of symptoms of infarction and appearance and disappearance of enzyme. Arch Intern Med 1980; 140:329-34.
4. Tsung SH. Several conditions causing elevation of serum CK-MB and CK-BB. Am J Clin Pathol 1981; 75:711-5.
5. Ohman EM, Christenson RH, Califf RM, George BS, Samaha JK, Kereiakes DJ, et al. for the TAMI 7 study group. Noninvasive detection of reperfusion afterthrombolysis based on serum creatine kinase MB changes and clinical variables. Am Heart J 1993; 126:819-26.
6. Sweetser DA, Heuckeroth RO, Gordon JI. The metabolic significance of mammalian fatty acid-binding proteins: abundant proteins in search of a function. Ann Rev Nutr 1987; 7:337-59.
7. Veerkamp JH, Peeters RA, Maatman RGHJ. Structural and functional features of different types of cytoplasmic fatty acid binding proteins. Biochim Biophys Acta 1991; 1081:1-24.
8. Veerkamp JH, Maatman RGHJ. Cytoplasmic fatty acid-binding proteins: their structure and genes. Prog Lipid Res 1995; 34:17-52.
9. Schaap FG, Van der Vusse GJ, Glatz JFC. Fatty acid-binding proteins in the heart. Mol Cell Biochem 1998; 180:43-51.
10. Glatz JFC, Paulussen RJA, Veerkamp JH. Fatty acid-binding proteins from heart. Chem Phys Lipids 1985; 8:115-29.
11. Knowlton AA. Leakage of heart fatty acid-binding protein with ischemia and reperfusion in the rat. J Mol Cell Cardiol 1989; 21:577-83.
12. Vork MM, Glatz JFC, Surtel DAM, Knubben HJM, Van der Vusse GJ. A sandwich enzyme linked immuno-sorbent assay for the determination of rat heart fatty acid-binding protein using the streptavidin-biotin system. Application to tissue and effluent samples from normoxic rat heart reperfusion. Biochim Biophys Acta 1991; 1075:199-205.
13. Sohmiya K, Tanaka T, Tsuji R, Yoshimoto K, Nakayama Y, Hirota Y, et al. Plasma and urinary heart-type cytoplasmic fatty acid-binding protein in coronary occlusion and reperfusion induced myocardial injury model. J Mol Cell Cardiol 1993; 25:1413-26.
14. Tanaka T, Hirota Y, Sohmiya K, Nishimura S, Kawamura K. Serum and urinary human heart fatty acid-binding protein in acute myocardial infarction. Clin Biochem 1991; 24:195-201.
15. Kleine AH, Glatz JFC, Van Nieuwenhoven FA, Van der Vusse GJ. Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man. Mol Cell Biochem 1992; 116:155-62.
16. Tsuji R, Tanaka T, Sohmiya K, Hirota Y, Yoshimoto K, Kinoshita K, et al. Human heart-type cytoplasmic fatty acid-binding protein in serum and urine during hyperacute myocardial infarction. Int J Cardiol 1993; 41:209-17.
17. Glatz JFC, Van der Vusse GJ, Simoons ML, Kragten JA, Van Dieijen-Visser MP, Hermens WT. Fatty acid-binding protein and the early detection of acute myocardial infarction. Clin Chim Acta 1998; 272:87-92.
18. Ohkaru Y, Asayama K, Ishii H, Nishimura S, Sunahara N, Tanaka T, et al. Development of a sandwich enzyme-linked immunosorbent assay for the determination of human heart type fatty acid-binding protein in plasma and urine by using two different monoclonal antibodies specific for human heart fatty acid-binding protein. J Immunol Methods 1995; 178:99-111.
19. Miyoshi K, Saito S, Kawai H, Kondo A, Iwasa M, Hayashi T, et al. Radioimmunoassay for human myoglobin methods and results in patients with skeletal muscle or myocardial disorders. J Lab Clin Med 1978; 92:341-52.
20. Roxin L-E, Cullhed I, Groth T, Hallgren T, Venge P. The value of serum myoglobin determinations in the early diagnosis of acute myocardial infarction. Acta Med Scand 1984; 215:417-25.
21. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143:29-36.
22. Sanders GT, Schouten Y, DeWinter RJ, Bonnell R, Laurino JP, Voelker, M. Evaluation of human heart type fatty acid-binding protein assay for early detection of myocardial infarction. Clin Chem 1998; 44:A132.
23. Ishii J, Wang J-H, Naruse H, Taga S, Kinoshita M, Kurokawa H, et al. Serum concentrations of myoglobin vs human heart-type cytoplasmic fatty acid-binding protein in early detection of acute myocardial infarction. Clin Chem 1997; 43:1372-8.
24. Yoshimoto K, Tanaka T, Sohmiya K, Tsuji R, Okamoto F, Kawamura K, et al. Human heart-type cytoplasmic fatty acid-binding protein as an indicator of acute myocardial infarction. Heart Vessels 1995; 10:304-9.
25. Van Nieuwenhoven FA, Kleine AH, Wodzig KWH, Hermens WT, Kragten HA, Maessen JG, et al. Discrimination between myocardial and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid-binding protein. Circulation 1995; 92:2848-54.
26. Kragten JA, Van Nieuwenhoven FA, Van Dieijen-Visser MP, Theunissen PHMH, Hermens WT, Glatz JFC. Distribution of myoglobin and fatty acid-binding protein in human cardiac autopsies. Clin Chem 1996; 42:337-8.
27. Ishii J, Nagamura Y, Nomura M, Wang J-H, Taga S, Kinoshita M, et al. Early detection of successful coronary reperfusion based on serum concentration of human heart-type cytoplasmic fatty acid-binding protein. Clin Chim Acta 1997; 262:13-27.
28. Glatz JFC, Kleine AH, Van Nieuwenhoven FA, Hermens WT, Van Dieijen-Visser MP, Van der Vusse GJ. Fatty-acid-binding protein as a plasma marker for the estimation of myocardial infarct size in humans. Br Heart J 1994; 71:135-40.
29. Wodzig KWH, Pelsers MMAL, Van Dieijen-Visser MP, Kragten JA, Hermens WT, Van der Vusse GJ, et al. Fatty acid-binding protein as predictive non-enzymatic marker of acute myocardial infarct size in humans. Ned Tijdschr Klin Chem 1996; 21:98-9.
30. Wodzig KWH, Kragten JA, Hermens WT, Glatz JFC, Van Dieijen-Visser MP. Estimation of myocardial infarct size from plasma myoglobin or fatty acid-binding protein. Influence of renal function. Eur J Clin Chem Clin Biochem 1997; 35:191-8.
31. Suzuki K, Sawa Y, Kadoba K, Takahashi T, Ichikawa H, Kagisaki K, et al. Early detection of cardiac damage with heart fatty acid-binding protein after cardiac operations. Ann Thorac Surg 1998; 65:54-8.